Faculty profile

Arleigh McCurdy

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Ottawa

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Just the facts: tumour lysis syndrome.
CJEM · 2026
Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.
Nature · 2026
Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline
Journal of Clinical Oncology · 2026

All 58 publications

58 publications.

Just the facts: tumour lysis syndrome.

Long B, McCurdy A, Rosenberg H

CJEM2026

DOI: 10.1007/s43678-026-01197-0 PMID: 42324426

Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

St Paul M, Hendrikse LD, Ying F, Snow BE, Luo P, Helke S, Smith LK, Hilal A, Abelman DD, Ramamurthy N, Nault H, Wei EN, Gold MJ, Tobin C, Lien SC, Liu Y, Zhou W, Zhang X, Nguyen D, Agbede O, Pedersen S, Eagles J, Saunders ME, Berger T, Wakeham A, Scott DS, Ly D, de Campos CB, Liang G, Zheng C, Wilson WV, Masih-Khan E, White D, McCurdy A, Louzada ML, Kotb R, Chu MP, Parkin S, Reece D, Gul E, Tiedemann R, Pugh TJ, Hirano N, Ohashi PS, Stewart AK, Trudel S, Mak TW

Nature2026

DOI: 10.1038/s41586-026-11055-9 PMID: 42749802

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Hicks LK, Messersmith HJ, Al Hadidi S, Banerjee R, Derman BA, Kumar S, Wildes TM, Bal S, Bhella S, Chmielewski C

Journal of Clinical Oncology202611 citations

DOI: 10.1200/jco-25-02587

Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Haider I, Leong DP, Shahid O, Louzada M, McCurdy A, Pond GR, Cameron R, Balitsky AK, Britto J, Aljama M

Clinical Lymphoma, Myeloma and Leukemia20261 citations

DOI: 10.1016/j.clml.2025.09.007

Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report

Louzada ML, Reece D, Venner CP, White D, Su J, Chu MP, Zepeda VHJ, Mccurdy A, Song K, Mian H

Blood Neoplasia2026

DOI: 10.1016/j.bneo.2026.100215

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Bhella S, Agbayani G, Hueniken K, Vijenthira A, Wilkin AM, Sebag M, Wang P, Hicks LK, Hay AE, Hosseini-Moghaddam SM

Blood advances2026

DOI: 10.1182/bloodadvances.2025018117

Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

Varghese J, Venner CP, Louzada M, Reece D, White D, Sharma S, Su J, Chu MP, Jimenez-Zepeda VH, McCurdy A

Clinical Lymphoma, Myeloma and Leukemia2026

DOI: 10.1016/j.clml.2025.10.019

Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database

Kaedbey R, Venner CP, Reece D, Hay K, Gul E, Su J, McCurdy A, Chu MP, Jimenez-Zepeda VH, Song K

Clinical Lymphoma, Myeloma and Leukemia2026

DOI: 10.1016/j.clml.2025.10.026

An emergency medicine review: Multiple myeloma and its complications.

Long B, McCurdy A, Koyfman A, Rosenberg H

The American journal of emergency medicine2025

DOI: 10.1016/j.ajem.2024.11.073 PMID: 39643958

Exploring what matters most to patients in relapsed refractory multiple myeloma treatment: a Canadian discrete choice experiment with patients, caregivers and physicians.

Hall R, Chua GN, Macfarlane B, Plante RK, Shi K, Soltys S, McCurdy A, Elias M, Ranger J

BMC cancer2025

DOI: 10.1186/s12885-025-14490-5 PMID: 40597849

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Arleigh McCurdy

Research

Latest papers

Just the facts: tumour lysis syndrome.

Identification of broadly tumour-reactive &#x3b3;&#x3b4; TCRs from multiple myeloma.

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database

An emergency medicine review: Multiple myeloma and its complications.

Exploring what matters most to patients in relapsed refractory multiple myeloma treatment: a Canadian discrete choice experiment with patients, caregivers and physicians.

Frequent collaborators

Hira Mian

Donna Reece

Martha Louzada

Michael Sebag

Alissa Visram

Amaris Karin Balitsky

Gregory Pond

Hsien Seow

Natasha Kekre

Mohammed Aljama

Suzanne Trudel

David Allan

Harold Atkins

Bram Rochwerg

Darryl Leong

Christopher McCudden

Christopher Bredeson

Mohan Biyani

Martine Puts

Michael Chu

Stephen Betschel

Lothar Huebsch

Navdeep Tangri

Ron Wald

Shabbir Alibhai

Shelly Bolotin

Mitchell Sabloff

Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.